To Lucy
SAB Biotherapeutics, Inc. · See Remarks
To Lucy is listed in filings as See Remarks at SAB Biotherapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 5, 2026, including 3 public disclosures. Recent filings connect the profile to SAB Biotherapeutics, Inc. (SABS). The current snapshot covers public activity from Aug 13, 2024 to Feb 5, 2026. Reported amounts are shown as $10.7M to $293.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||